The review article entitled "Exosomes as potential diagnosis and treatment for liver cancer " recently published in World Journal of Gastrointestinal Oncology 2022; 14: 334-347 concluded that exosomes can be used as effective biomarkers or therapeutic biotargets in liver cancer. Exosomes are a hot spot in the field of tumor diagnosis and treatment research. We had also previously published a review on exosomes and tumors. In this letter to the editor, we summarize the clinical application prospects and current challenges of exosomes.
第一作者机构：[1]Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, 45 Changchun St, Beijing 100053, Peoples R China[*1]Academic Research, Surgeon, Department of General Surgery, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China
通讯作者：
通讯机构：[1]Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, 45 Changchun St, Beijing 100053, Peoples R China[*1]Academic Research, Surgeon, Department of General Surgery, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China
推荐引用方式(GB/T 7714)：
Fang Zhen,Ding Yi-Xuan,Li Fei.Exosomes: Promising biomarkers and targets for cancer[J].WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY.2022,14(8):1594-1596.doi:10.4251/wjgo.v14.i8.1594.
APA：
Fang, Zhen,Ding, Yi-Xuan&Li, Fei.(2022).Exosomes: Promising biomarkers and targets for cancer.WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY,14,(8)
MLA：
Fang, Zhen,et al."Exosomes: Promising biomarkers and targets for cancer".WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY 14..8(2022):1594-1596
